HSP : Analysis & Opinions

  1. Europe Regulator Approves Pfizer Buyout of Hospira

    August 7, 2015
    Pfizer (NYSE: PFE) has gotten the green light from Europe's antitrust regulator to acquire fellow pharmaceutical Hospira ...
  2. Most Important Mergers And Acquisitions Of 2015

    June 15, 2015
    Nearly halfway through the year, 2015 is proving to be a big one for mergers and acquisitions.
  3. How to Profit from the Generic Drug Trend

    June 3, 2015
    Generic drugs are poised to steal market share as patent protections on a number of branded drugs expire. Investors should ...
  4. Pfizer Earnings Preview: 5 Things You Need to Know

    April 21, 2015
    Pfizer may not be the growth giant it was when it was riding cholesterol-fighting drug Lipitor's coattails to success, but ...
  5. This $110 Billion Pharma Revolution Could Make Or Break Your ...

    February 19, 2015
    For sufferers of Rheumatoid Arthritis, Crohn's Disease, psoriasis, colitis and other auto-immune diseases, AbbVie, Inc.'s ...
  6. The Pharma Revolution That Could Rock Your Portfolio

    February 19, 2015
    For sufferers of Rheumatoid Arthritis, Crohn's Disease, psoriasis, colitis and other auto-immune diseases, AbbVie, Inc.'s ...
  7. Warning: 5 Popular Stocks You Need To Sell Now

    February 11, 2015
    These are five of the most widely owned stocks in the market. You have, without a doubt, heard of them, and it's very possible ...
  8. Warning: 5 Popular Stocks You Need to Consider Selling Now

    February 11, 2015
    These are five of the most widely owned stocks in the market. You have, without a doubt, heard of them, and it's very possible ...
  9. A Simple Way To Profit From The Fight Against Drug Abuse

    August 14, 2014
    From time to time we at StreetAuthority propose investments in "controversial" stocks that many of our readers ...
  10. Amgen Chased By The Bubble

    May 8, 2013
    Amgen really needs the pipeline to come through to support this valuation.
  11. In A Growth-Starved Sector, Becton Dickinson Rules

    May 3, 2013
    Becton Dickinson is a great business, but investors seem to be too willing to overpay for today's relatively stronger growth. ...
  12. If CareFusion Can Execute, This Is A Major Bargain

    November 9, 2011
    CareFusion has to make some improvements, but it could really reward investors.
  13. Teva And Mylan Show Some Value Remains In Generics

    August 4, 2011
    These two generics companies seem to be heading in opposite directions, but the values are similar.
  14. Small Med-Tech Names You Should Know

    April 15, 2010
    These three med-tech names aren't well-known by most investors, but they should be.
  15. Baxter A Healthy Healthcare Holding

    April 22, 2009
    Baxter's recent results demonstrate why it continues as a leader in its industry and should be considered a core healthcare ...
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!